Business
Cognition Therapeutics Announces New Episode of “Conversations” Podcast: Insights for the Primary Care Physician: Recognizing Dementia with Lewy Bodies
PURCHASE, N.Y., March 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”) has released its fourth
About this update from Cognition Therapeutics, Inc.
[{"type":"text","content":"PURCHASE, N.Y., March 27, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”) has released its fourth “Conversations” video podcast, a two-part conversation about dementia with Lewy bodies (DLB) focusing on the overlapping symptoms and pathology of DLB, Alzheimer's and Parkinson's diseases. Four neuroscience thought leaders with a wealth of experience in diagnosing and managing dementia share their insights into the nuanced symptoms and signs that help them differentiate DLB from other dementias such as Alzheimer’s disease. Episode 4: “Insights for the Primary Care Physician: Recognizing Dementia with Lewy Bodies” features a conversation between: Brendan Kelley, M.D., (moderator) vice chair for clinical operations at the Peter O’Donnell Jr. Brain Institute and a professor in the department of neurology at the University of Texas Southwestern Medical Center;Sarah B. Berman, M.D., Ph.D., associate professor in the departments of neurology and clinical & translational science at the University of Pittsburgh and director of DLB programs at the university’s Alzheimer’s Disease Research Center;James Leverenz, M.D., director of the Cleveland Clinic Lou Ruvo Center for Brain Health; andDavid Shprecher, D.O., the movement disorder director at Banner Sun Health Research Institute and a clinical associate professor at the University of Arizona This twenty-five-minute conversation is presented in two primary sections: The intersection of Alzheimer's and DLB: epidemiology, symptoms and co-pathology Core clinical features of DLBBiomarkers for DLB Practical insights for community physicians Frequency of missed or delayed diagnosis of DLBFacets of patient-reported memory loss: changes in cognitive vs. executive functionNuances of psychological symptoms: hallucinations, misperceptions, delusions and false beliefsMedical and emotional importance of an accurate diagnosis Cognition Therapeutics welcomes comments, questions and feedback on this and other Conversations episodes which may be submitted at [email protected]. We’d love to hear your thoughts! About Dementia with Lewy BodiesAn estimated 1.4 million Americans are living with DLB, a progressive disease that accounts for approximately 5-10% of all dementia cases. DLB, has overlapping pathology and symptomology of Parkinson’s and Alzheimer’...